Nanocarriers for treatment of dermatological diseases: Principle, perspective and practices

Eur J Pharmacol. 2021 Jan 5:890:173691. doi: 10.1016/j.ejphar.2020.173691. Epub 2020 Oct 28.

Abstract

Skin diseases are the fourth leading non-fatal skin conditions that act as a burden and affect the world economy globally. This condition affects the quality of a patient's life and has a pronounced impact on both their physical and mental state. Treatment of these skin conditions with conventional approaches shows a lack of efficacy, long treatment duration, recurrence of conditions, systemic side effects, etc., due to improper drug delivery. However, these pitfalls can be overcome with the applications of nanomedicine-based approaches that provide efficient site-specific drug delivery at the target site. These nanomedicine-based strategies are evolved as potential treatment opportunities in the form of nanocarriers such as polymeric and lipidic nanocarriers, nanoemulsions along with emerging others viz. carbon nanotubes for dermatological treatment. The current review focuses on challenges faced by the existing conventional treatments along with the topical therapeutic perspective of nanocarriers in treating various skin diseases. A total of 213 articles have been reviewed and the application of different nanocarriers in treating various skin diseases has been explained in detail through case studies of previously published research works. The toxicity related aspects of nanocarriers are also discussed.

Keywords: Conventional formulations; Nanocarriers; Skin diseases; Stratum corneum.

Publication types

  • Review

MeSH terms

  • Administration, Cutaneous
  • Animals
  • Drug Carriers / administration & dosage*
  • Drug Carriers / metabolism
  • Drug Delivery Systems / methods
  • Humans
  • Nanospheres / administration & dosage*
  • Nanospheres / metabolism
  • Skin / drug effects*
  • Skin / metabolism
  • Skin Diseases / drug therapy*
  • Skin Diseases / metabolism

Substances

  • Drug Carriers